Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis

Chest

Volumn 123, Issue 6, 2003, Pages 2007-2011

  Enomoto, Tatsuji ^a   Usuki, Jiro ^b   Azuma, Arata ^b   Nakagawa, Takashi ^b   Kudoh, Shoji ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Case control study; Diabetes mellitus; Pulmonary fibrosis; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; IDIOPATHIC DISEASE; LIFESTYLE; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0037790724     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.6.2007     Document Type: Article

References (26)

1. King TE. Idiopathic pulmonary fibrosis. In: Schwarz MI, King TE, eds. Interstitial lung disease. 2nd ed. St. Louis, MO: Mosby-Year Book, 1993; 367-403
2. Iwai K, Mori T, Yamada N, et al. Idiopathic pulmonary fibrosis: epidemiologic approach to occupational exposure. Am J Respir Crit Care Med 1994; 150:670-675
3. Hubbard B, Lewis S, Richards K, et al. Occupational to exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347:284-289
4. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155:242-248
5. Hubbard R, Venn A, Smith C, et al. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a study. Am J Respir Crit Care Med 1998; 157:743-747
6. Tobin RW, Pope CE II, Pellegrini CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158:1804-1808
7. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A study of environmental exposure to dust. BMJ 1990; 301:1015-1017
8. Baumgartner KB, Samet JM, Coultas DB, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter study. Am J Epidemiol 2000; 152:307-315
9. Billings CG, Howard P. Hypothesis: exposure to solvents may cause fibrosing alveolitis. Eur Respir J 1994; 7:1172-1176
10. Mannino DM, Etzel RA, Parrish RG. Pulmonary fibrosis deaths in the United States, 1979-1991: an analysis of multiple-cause mortality data. Am J Respir Crit Care Med 1996; 153:1548-1552
11. Matsuzawa Y. Life style-related disease [in Japanese]. Nippon Binsho 2001; 59:188-194
12. Idiopathic pulmonary fibrosis: diagnosis and treatment; international consensus statement. Am J Respir Crit Care Med 2000; 161:646-664
13. Matsuzawa Y, Inoue S, Ikeda S, et al. New evaluation of obesity and diagnostic criteria of obesity as a disease for Japanese [in Japanese]. Himan Kenkyu 2000; 6:18-28
14. Report of a WHO expert committee: hypertension control. Geneva, Switzerland: World Health Organization, 1996; WHO Technical Report Series No, 862
15. Kuzuya T, Nakagawa S, Sato Y, et al. Classification and diagnostic criteria of diabetes mellitus in Japan [in Japanese]. Tonyobyo 1999; 42:385-404
16. Hata Y, Mabuchi H, Saito Y, et al. Guideline for diagnosis and treatment of hyperlipidemias in adults [in Japanese]. Domyakukoka 1997; 25:1-34
17. Taniguchi A, Kamaya N. Diagnostic criteria and classification of gout and hyperuricemia [in Japanese]. Naika 2000; 85: 1749-1751
18. Akazawa Y. Epidemiological study of diabetes mellitus. Tonyobyo Chosakenkyu Houkokusho. Tokyo, Japan: Ministry of Health and Welfare, 1994; 3-9
19. Suarez T, Carrillo G, Contreras E, et al. Increase prevalence of diabetes mellitus in patients with interstitial lung disease [abstract]. Am J Respir Crit Care Med 2000; 161:A829
20. Abramowitz S, George CL, Maurice JS. Chronic respiratory disease and diabetes. Rev Allergy 1969; 23:972-977
21. Suga T, Sugiyama Y, Kitamura S. Clinical study of patients with idiopathic interstitial pneumonia accompanied by diabetes mellitus. Jpn J Thorac Dis 1994; 32:1131-1135
22. Crystal RG, Fulmer JD, Roberts WC, et al. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphice, cytologic, and biochemical aspects. Ann Intern Med 1976; 85:769-788
23. Richard AD. Serum lactic dehydrogenese activity and diffuse interstitial pneumonia. JAMA 1968; 204:1193-1195
24. Enomoto T, Usuki J, Azuma A, et al. The influence of hyperglycemia to the severity of bleomycin induced lung fibrosis in mice [abstract]. Am J Respir Crit Care Med 2000; 161:A828
25. Matsuse T, Ohga E, Teramoto S, et al. Immunohistochemieal localization of advanced glycation end products in pulmonary fibrosis. J Clin Pathol 1998; 51:515-519
26. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318:1315-1321